Dyne Therapeutics Statistics
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.97+0.57 (+3.70%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Dyne Therapeutics by the numbers
Dyne Therapeutics has a market capitalization of $2.98 billion based on 186.75M shares outstanding. With trailing EPS of $-3.42, Dyne Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.9% below its 50-day average and 18.4% below its 200-day average.
Average daily trading volume is 2.77M shares, or about $44.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DYN valuation vs. peer median
| Metric | DYN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.98B | $2.80B | +7% |
| Avg. volume | 2.77M | 1.33M | +108% |
Peer median across 8 companies: ELVN, ARQT, RCUS, ZLAB, MRVI, PGEN, MBX, NAMS.
Valuation
- Market cap
- $2.98B
- EPS (TTM)
- $-3.42
- Shares outstanding
- 186.75M
Price and trading
- Previous close
- 15.40
- Open
- 15.40
- Day range
- 15.25 – 16.12
- 52-week range
- 13.73 – 27.31
- 52-week change
- +14.48%
- Beta
- —
- Volume
- 3.49M
- Average volume
- 2.77M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.98B
- Forward Pe
- -4.79
- Eps
- -3.42
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.31
- Week52 Low
- 13.73
- Avg Volume
- 2.77M
- Shares Outstanding
- 186.75M
- Ma50
- 22.14
- Ma200
- 19.58
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -41.51%
- Pct From52w Low
- 16.36%